Work

Erratum

Year: 2007
Type: erratum
Abstract: In (1), the following errors occurred: On p90, the following footnote should have appeared after Table 1: ''** all insulins used must be produced under Good Manufacturing Practice/Good Laboratory Practice conditions.''On p91 under the section headed ''Detemir'', the text should have read: ''In a pediatric study, 70% of the patients used detemir twice daily (29)(A) On p93, the text should have read: ''Fat mass (large subcutaneous fat thickness (82)[B], lipohypertrophy (83) [B], also with rapid-acting analogues [B] -.slower absorption)'' The associated reference for this is: Johansson UB, Amsberg S, Hannerz L, Wredling R, Adamson U, Arnqvist HJ, Lins PE.Impaired absorption of insulin aspart from lipohypertrophic injection sites.Diabetes Care 2005: 28: 2025-2027.Also on p93, the text should have stated: ''Subcutaneous vs. intramuscular injection (im injection -. faster absorption in thigh) (85)[B].Accidental im injections can cause variable glucose control [E].''
Language: Dutch
Field: Medicine
Open Access status: bronze
OpenAlex ID: W4255691773
Cites: 1
Cited by:
Related to: 10